515 related articles for article (PubMed ID: 3939479)
1. Animal viruses of economic importance: genetic variation, persistence, and prospects for their control.
Hudson JB
Pharmacol Ther; 1985; 30(2):115-226. PubMed ID: 3939479
[No Abstract] [Full Text] [Related]
2. Replication-defective viruses as vaccines and vaccine vectors.
Dudek T; Knipe DM
Virology; 2006 Jan; 344(1):230-9. PubMed ID: 16364753
[TBL] [Abstract][Full Text] [Related]
3. A proposed treatment for pathogenic enveloped viruses having high rates of mutation or replication.
Roe K
Scand J Immunol; 2020 Sep; 92(3):e12928. PubMed ID: 32640050
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology and viral infections.
Reynolds KS
Clin Pharmacol Ther; 2010 Nov; 88(5):569-73. PubMed ID: 20959836
[No Abstract] [Full Text] [Related]
5. Viral vectors for veterinary vaccines.
Sheppard M
Adv Vet Med; 1999; 41():145-61. PubMed ID: 9890015
[TBL] [Abstract][Full Text] [Related]
6. RNA interference & inhibition of viruses.
Gadkari DA
Indian J Med Res; 2005 Mar; 121(3):147-50. PubMed ID: 15802755
[No Abstract] [Full Text] [Related]
7. Medical consequences of persistent viral infection.
Southern P; Oldstone MB
N Engl J Med; 1986 Feb; 314(6):359-67. PubMed ID: 3511377
[No Abstract] [Full Text] [Related]
8. [Prospects of studying the antiviral properties of cytokines].
Votiakov VI; Gribkova NV
Antibiot Khimioter; 1990 Oct; 35(10):13-8. PubMed ID: 1703757
[No Abstract] [Full Text] [Related]
9. Viral interference-dominance of mutant viruses over wild-type virus in mixed infections.
Whitaker-Dowling P; Youngner JS
Microbiol Rev; 1987 Jun; 51(2):179-91. PubMed ID: 3299027
[No Abstract] [Full Text] [Related]
10. Overview of viruses relevant to blood transfusion.
Schilt U
Curr Stud Hematol Blood Transfus; 1989; (56):1-8. PubMed ID: 2642782
[No Abstract] [Full Text] [Related]
11. [On the achievements and prospects of virus research at the St. S. Nicolau Institutul de virusologie].
Cajal N
Stud Cercet Inframicrobiol; 1971; 22(4):287-307. PubMed ID: 4942522
[No Abstract] [Full Text] [Related]
12. Live virus vaccines for use in animals.
Bostock CJ
Dev Biol Stand; 1995; 84():41-8. PubMed ID: 7796966
[No Abstract] [Full Text] [Related]
13. Future prospects for antiviral agents and new approaches.
Galasso GJ
J Antimicrob Chemother; 1984 Aug; 14 Suppl A():127-36. PubMed ID: 6208182
[No Abstract] [Full Text] [Related]
14. Vaccines for emerging and re-emerging viral diseases of companion animals.
McVey DS; Kennedy M
Vet Clin North Am Small Anim Pract; 2008 Jul; 38(4):903-17, ix-x. PubMed ID: 18501286
[TBL] [Abstract][Full Text] [Related]
15. Viral quasispecies.
Eigen M
Sci Am; 1993 Jul; 269(1):42-9. PubMed ID: 8337597
[No Abstract] [Full Text] [Related]
16. Population dynamics of immune responses to persistent viruses.
Nowak MA; Bangham CR
Science; 1996 Apr; 272(5258):74-9. PubMed ID: 8600540
[TBL] [Abstract][Full Text] [Related]
17. Update on virology: the nature of viruses and control of the diseases they cause.
Griffiths P
Trans Med Soc Lond; 1988-1989; 105():46-9. PubMed ID: 3153118
[No Abstract] [Full Text] [Related]
18. [Advances in Avian Antiviral Innate Immune Effectors].
Zeng M; Chen S; Wang M; Chen A
Bing Du Xue Bao; 2016 Sep; 32(5):627-33. PubMed ID: 30003769
[TBL] [Abstract][Full Text] [Related]
19. Antiviral agents in practice.
Can Med Assoc J; 1968 Jun; 98(22):1066-8. PubMed ID: 5661063
[No Abstract] [Full Text] [Related]
20. Review of companion animal viral diseases and immunoprophylaxis.
Patel JR; Heldens JG
Vaccine; 2009 Jan; 27(4):491-504. PubMed ID: 19041354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]